Julie Standley is the Vice President Clinical Laboratory Sciences in the Clinical Design Delivery and Analysis (CDDA) organization at Eli Lilly supporting clinical trial laboratory planning, execution, and data delivery. She has worked in the Pharmaceutical Industry for over 20 years holding several organizational and project leadership positions in drug development, clinical development, clinical laboratory, clinical supply chain, and chemistry, manufacturing and controls (CM&C). She has delivered on many transformational initiatives to speed drug development and drive operational efficiency through her career. Prior to Eli Lilly, Julie worked in the development, quality, and manufacturing organizations at Aventis Behring. Julie holds an MBA from Olivet Nazarene University and a B.S. in Bioengineering from University of Illinois.